Essential roles of sphingosine 1-phosphate receptor types 1 and 3 in human hepatic stellate cells motility and activation

Journal of Cellular Physiology

Volumn 226, Issue 9, 2011, Pages 2370-2377

  Liu, Xihong ^a   Yue, Shi ^a   Li, Changyong ^a   Yang, Lin ^a   You, Hong ^b   Li, Liying ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 (2,6 DICHLORO 4 PYRIDINYL) 1 (1,3 DIMETHYL 4 ISOPROPYL 1H PYRAZOLO[3,4 B]PYRIDIN 6 YL)SEMICARBAZIDE; 5 (4 PHENYL 5 TRIFLUOROMETHYL 2 THIENYL) 3 (3 TRIFLUOROMETHYLPHENYL) 1,2,4 OXADIAZOLE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; HYDROXYPROLINE; PROCOLLAGEN ALPHA 1; PROTEIN; SMALL INTERFERING RNA; SMOOTH MUSCLE ACTIN; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR 1; SPHINGOSINE 1 PHOSPHATE RECEPTOR 2; SPHINGOSINE 1 PHOSPHATE RECEPTOR 3; SPHINGOSINE KINASE 1; UNCLASSIFIED DRUG; W146;

ARTICLE; CELL ACTIVATION; CELL LINE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STELLATE CELL; WESTERN BLOTTING;

CELL LINE; CELL MOVEMENT; GENE SILENCING; HEPATIC STELLATE CELLS; HUMANS; LYSOPHOSPHOLIPIDS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); RECEPTORS, LYSOSPHINGOLIPID; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 79958736368     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22572     Document Type: Article

References (46)

1. Alvarez SE, Milstien S, Spiegel S. 2007. Autocrine and paracrine roles of sphingosine-1-phosphate. Trends Endocrinol Metab 18: 300-307.
2. Banno Y, Takuwa Y, Akao Y, Okamoto H, Osawa Y, Naganawa T, Nakashima S, Suh PG, Nozawa Y. 2001. Involvement of phospholipase D in sphingosine 1-phosphate-induced activation of phosphatidylinositol 3-kinase and Akt in Chinese hamster ovary cells overexpressing EDG3. J Biol Chem 276: 35622-35628.
3. Bataller R, Brenner DA. 2005. Liver fibrosis. J Clin Invest 115: 209-218.
4. Becciolini L, Meacci E, Donati C, Cencetti F, Rapizzi E, Bruni P. 2006. Sphingosine 1-phosphate inhibits cell migration in C2C12 myoblasts. Biochim Biophys Acta 1761: 43-51.
5. Blom T, Bergelin N, Meinander A, Lof C, Slotte JP, Eriksson JE, Tornquist K. 2010. An autocrine sphingosine-1-phosphate signaling loop enhances NF-kappa B-activation and survival. BMC Cell Biol 11: 45.
6. Boguslawski G, Grogg JR, Welch Z, Ciechanowicz S, Sliva D, Kovala AT, McGlynn P, Brindley DN, Rhoades RA, English D. 2002. Migration of vascular smooth muscle cells induced by sphingosine 1-phosphate and related lipids: Potential role in the angiogenic response. Exp Cell Res 274: 264-274.
7. Brunati AM, Tibaldi E, Carraro A, Gringeri E, D'Amico F, Toninello A, Massimino ML, Pagano MA, Nalesso G, Cillo U. 2008. Cross-talk between PDGF and S1P signalling elucidates the inhibitory effect and potential antifibrotic action of the immunomodulator FTY720 in activated HSC-cultures. Biochim Biophys Acta 1783: 347-359.
8. Cencetti F, Bernacchioni C, Nincheri P, Donati C, Bruni P. 2010. Transforming growth factor-beta 1 induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1/S1P(3) axis. Mol Biol Cell 21: 1111-1124.
9. Davaille J, Gallois C, Habib A, Li LY, Mallat A, Tao JC, Levade T, Lotersztajn S. 2000. Antiproliferative properties of sphingosine 1-phosphate in human hepatic myofibroblasts-A cyclooxygenase-2 mediated pathway. J Biol Chem 275: 34628-34633.
10. Davaille J, Li LY, Mallat A, Lotersztajn S. 2002. Sphingosine 1-phosphate triggers both apoptotic and survival signals for human hepatic myofibroblasts. J Biol Chem 277: 37323-37330.
11. Friedman SL. 2000. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275: 2247-2250.
12. Friedman SL. 2008a. Hepatic stellate cells: Protean, multifunctional, and enigmatic cells of the liver. Physiol Rev 88: 125-172.
13. Friedman SL. 2008b. Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655-1669.
14. Gellings Lowe N, Swaney JS, Moreno KM, Sabbadini RA. 2009. Sphingosine-1-phosphate and sphingosine kinase are critical for transforming growth factor-beta-stimulated collagen production by cardiac fibroblasts. Cardiovasc Res 82: 303-312.
15. Goparaju SK, Jolly PS, Watterson KR, Bektas M, Alvarez S, Sarkar S, Mel L, Ishii I, Chun J, Milstien S, Spiegel S. 2005. The S1P(2) receptor negatively regulates platelet-derived growth factor-induced motility and proliferation. Mol Cell Biol 25: 4237-4249.
16. Hait NC, Oskeritzian CA, Paugh SW, Milstien S, Spiegel S. 2006. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim Biophys Acta 1758: 2016-2026.
17. Hannun YA, Obeid LM. 2008. Principles of bioactive lipid signalling: Lessons from sphingolipids. Nat Rev Mol Cell Biol 9: 139-150.
18. Hashimoto M, Wang XQ, Mao LJ, Kobayashi T, Kawasaki S, Mori N, Toews ML, Kim HJ, Cerutis DR, Liu XD, Rennard SI. 2008. Sphingosine 1-phosphate potentiates human lung fibroblast chemotaxis through the S1P(2) receptor. Am J Resp Cell Mol Biol 39: 356-363.
19. Hla T. 2004. Physiological and pathological actions of sphingosine 1-phosphate. Semin Cell Dev Biol 15: 513-520.
20. Ikeda H, Yatomi Y, Yanase M, Satoh H, Maekawa H, Ogata I, Ozaki Y, Takuwa Y, Mochida S, Fujiwara K. 2000. Biological activities of novel lipid mediator sphingosine 1-phosphate in rat hepatic stellate cells. Am J Physiol 279: G304-G310.
21. Ikeda H, Satoh H, Yanase M, Inoue Y, Tomiya T, Arai M, Tejima K, Nagashima K, Maekawa H, Yahagi N, Yatomi Y, Sakurada S, Takuwa Y, Ogata I, Kimura S, Fujiwara K. 2003. Antiproliferative property of sphingosine 1-phosphate in rat hepatocytes involves activation of Rho via Edg-5. Gastroenterology 124: 459-469.
22. Ikeda H, Watanabe N, Ishii I, Shimosawa T, Kume Y, Tomiya T, Inoue Y, Nishikawa T, Ohtomo N, Tanoue Y, Iitsuka S, Fujita R, Omata M, Chun J, Yatomi Y. 2009. Sphingosine 1-phosphate regulates regeneration and fibrosis after liver injury via sphingosine 1-phosphate receptor 2. J Lipid Res 50: 556-564.
23. Julien B, Grenard P, Teixeira-Clerc F, Van Nhieu JT, Li LY, Karsak M, Zimmer A, Mallat A, Lotersztajn S. 2005. Antifibrogenic role of the cannabinoid receptor CB2 in the liver. Gastroenterology 128: 742-755.
24. Keller CD, Rivera Gil P, Tolle M, van der Giet M, Chun J, Radeke HH, Schafer-Korting M, Kleuser B. 2007. Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P(3) and smad3 signaling. Am J Pathol 170: 281-292.
25. Kono Y, Nishiuma T, Nishimura Y, Kotani Y, Okada T, Nakamura S, Yokoyama M. 2007. Sphingosine kinase 1 regulates differentiation of human and mouse lung fibroblasts mediated by TGF-beta 1. Am J Resp Cell Mol Biol 37: 395-404.
26. Li LY, Grenard P, Van Nhieu JT, Julien B, Mallat A, Habib A, Lotersztajn S. 2003. Heme oxygenase-1 is an antifibrogenic protein in human hepatic myofibroblasts. Gastroenterology 125: 460-468.
27. Li CY, Jiang XM, Yang L, Liu XH, Yue S, Li LY. 2009a. Involvement of sphingosine 1-phosphate (SIP)/S1P(3) signaling in cholestasis-induced liver fibrosis. Am J Pathol 175: 1464-1472.
28. Li CY, Kong YX, Wang H, Wang SL, Yu H, Liu X, Yang L, Jiang XM, Li LS, Li LY. 2009b. Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis. J Hepatol 50: 1174-1183.
29. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, Brinkmann V, Allende ML, Proia RL, Cyster JG. 2004. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427: 355-360.
30. Meriane M, Duhamel S, Lejeune L, Galipeau J, Annabi B. 2006. Cooperation of matrix metalloproteinases with the RhoA/Rho kinase and mitogen-activated protein kinase kinase-1/extracellular signal-regulated kinase signaling pathways is required for the sphingosine-1-phosphate-induced mobilization of marrow-derived stromal cells. Stem Cells 24: 2557-2565.
31. Min JK, Yoo HS, Lee EY, Lee WJ, Lee YM. 2002. Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatasel. Anal Biochem 303: 167-175.
32. Ohmori T, Yatomi Y, Okamoto H, Miura Y, Rile G, Satoh K, Ozaki Y. 2001. G(i)-mediated Cas tyrosine phosphorylation in vascular endothelial cells stimulated with sphingosine 1-phosphate-Possible involvement in cell motility enhancement in cooperation with Rho-mediated pathways. J Biol Chem 276: 5274-5280.
33. Okamoto H, Takuwa N, Yokomizo T, Sugimoto N, Sakurada S, Shigematsu H, Takuwa Y. 2000. Inhibitory regulation of Rac activation, membrane ruffling, and cell migration by the G protein-coupled sphingosine-1-phosphate receptor EDG5 but not EDG1 or EDG3. Mol Cell Biol 20: 9247-9261.
34. Paik JH, Chae SS, Lee MJ, Thangada S, Hla T. 2001. Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha(v)beta(3)- and beta(1)-containing integrins. J Biol Chem 276: 11830-11837.
35. Sakaida I, Terai S, Yamamoto N, Aoyama K, Ishikawa T, Nishina H, Okita K. 2004. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 40: 1304-1311.
36. Sanchez T, Hla T. 2004. Structural and functional characteristics of S1P receptors. J Cell Biochem 92: 913-922.
37. Sanna MG, Liao JY, Jo EJ, Alfonso C, Ahn MY, Peterson MS, Webb B, Lefebvre S, Chun J, Gray N, Rosen H. 2004. Sphingosine 1-phosphate (S1P) receptor subtypes S1P(1) and S1P(3), respectively, regulate lymphocyte recirculation and heart rate. J Biol Chem 279: 13839-13848.
38. Schwab SR, Pereira JP, Matloubian M, Xu Y, Huang Y, Cyster JG. 2005. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309: 1735-1739.
39. Spiegel S, Milstien S. 2003. Sphingosine-1-phosphate: An enigmatic signalling lipid. Nat Rev Mol Cell Biol 4: 397-407.
40. Spiegel S, English D, Milstien S. 2002. Sphingosine 1-phosphate signaling: providing cells with a direction. Trends Cell Biol 12: 236-242.
41. Sugimoto N, Takuwa N, Okamoto H, Sakurada S, Takuwa Y. 2003. Inhibitory and stimulatory regulation of Rac and cell motility by the G(12/13)-Rho and G(i) pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol Cell Biol 23: 1534-1545.
42. Swaney JS, Moreno KM, Gentile AM, Sabbadini RA, Stoller GL. 2008. Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye. Exp Eye Res 87: 367-375.
43. Takuwa N, Ohkura SI, Takashima SI, Ohtani K, Okamoto Y, Tanaka T, Hirano K, Usui S, Wang F, Du W, Yoshioka K, Banno Y, Sasaki M, Ichi I, Okamura M, Sugimoto N, Mizugishi K, Nakanuma Y, Ishii I, Takamura M, Kaneko S, Kojo S, Satouchi K, Mitumori K, Chun J, Takuwa Y. 2010. S1P(3)-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species. Cardiovasc Res 85: 484-493.
44. Teixeira-Clerc F, Julien B, Grenard P, Van Nhieu JT, Deveaux V, Li LY, Serriere-Lanneau V, Ledent C, Mallat A, Lotersztajn S. 2006. CB1 cannabinoid receptor antagonism: A new strategy for the treatment of liver fibrosis. Nat Med 12: 671-676.
45. Wang F, Van Brocklyn JR, Hobson JP, Movafagh S, Zukowska-Grojec Z, Milstien S, Spiegel S. 1999. Sphingosine 1-phosphate stimulates cell migration through a G(i)-coupled cell surface receptor-Potential involvement in angiogenesis. J Biol Chem 274: 35343-35350.
46. Xu L, Hui AY, Albanis E, Arthur MJ, O'Byrne SM, Blaner WS, Mukherjee P, Friedman SL, Eng FJ. 2005. Human hepatic stellate cell lines, LX-1 and LX-2: New tools for analysis of hepatic fibrosis. Gut 54: 142-151.